Peripheral Vascular Devices

Global Peripheral Vascular Devices Market to Reach US$16.0 Billion by 2030

The global market for Peripheral Vascular Devices estimated at US$12.7 Billion in the year 2024, is expected to reach US$16.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Angioplasty Stents, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$9.1 Billion by the end of the analysis period. Growth in the Angioplasty Balloon segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 3.6% CAGR

The Peripheral Vascular Devices market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Peripheral Vascular Devices Market - Key Trends and Drivers Summarized

Why Are Peripheral Vascular Devices Essential in Modern Medicine?

Peripheral vascular devices are critical tools in the diagnosis and treatment of diseases affecting the peripheral blood vessels, including arteries, veins, and lymphatic vessels outside of the heart and brain. These devices, which include stents, catheters, balloons, and filters, are used to manage conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and chronic venous insufficiency (CVI). The importance of these devices lies in their ability to restore proper blood flow, reduce the risk of complications, and improve patient outcomes. For instance, angioplasty balloons and stents are utilized to open narrowed or blocked arteries, enhancing blood circulation and preventing tissue damage. The development of minimally invasive techniques involving these devices has revolutionized vascular surgery, reducing recovery times and improving the quality of life for patients.

How Are Technological Advancements Shaping Peripheral Vascular Devices?

Technological advancements are significantly enhancing the functionality and efficacy of peripheral vascular devices. Innovations such as drug-eluting stents, which release medication to prevent restenosis, and bioresorbable stents, which gradually dissolve after restoring blood flow, represent significant breakthroughs in vascular treatment. Additionally, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are improving the precision of device placement and the assessment of vascular conditions. The integration of advanced materials, like shape-memory alloys and biocompatible polymers, is enhancing the durability and performance of these devices. Furthermore, the development of hybrid devices that combine multiple functions, such as drug delivery and mechanical support, is expanding the therapeutic options available to clinicians. These technological strides are making treatments safer, more effective, and less invasive.

What Are the Key Applications of Peripheral Vascular Devices?

Peripheral vascular devices have a wide range of applications across various medical disciplines. In interventional cardiology, these devices are used to treat PAD, which is characterized by the narrowing of peripheral arteries, typically in the legs, leading to pain and mobility issues. Endovascular treatments using balloons and stents help to reopen these arteries, restoring blood flow and alleviating symptoms. In vascular surgery, devices like grafts and endovascular aneurysm repair (EVAR) systems are essential for treating aneurysms, which are bulging or weakened areas in the vessel walls that can rupture if not managed properly. Additionally, peripheral vascular devices are crucial in managing venous diseases, such as DVT, where clot removal devices and filters prevent life-threatening complications like pulmonary embolism. The versatility and effectiveness of these devices in addressing various vascular conditions highlight their importance in contemporary medical practice.

What Factors Are Driving the Growth in the Peripheral Vascular Devices Market?

The growth in the peripheral vascular devices market is driven by several factors. One significant driver is the increasing prevalence of cardiovascular diseases and lifestyle-related conditions such as diabetes and hypertension, which heighten the risk of peripheral vascular disorders. Technological advancements that enhance the safety and efficacy of vascular devices are also propelling market growth, as they expand the range of treatable conditions and improve patient outcomes. Additionally, the aging global population is contributing to market expansion, as older adults are more susceptible to vascular diseases. The rising demand for minimally invasive procedures, which offer shorter recovery times and fewer complications compared to traditional surgeries, is further boosting the adoption of these devices. Moreover, increasing healthcare expenditure and improved access to advanced medical technologies in emerging markets are creating new opportunities for growth. These factors collectively ensure a robust growth trajectory for the peripheral vascular devices market, driven by the ongoing need for innovative and effective vascular treatments.

SCOPE OF STUDY:

The report analyzes the Peripheral Vascular Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Device Type (Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Other Device Types)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

• Abbott Laboratories
• B. Braun Melsungen AG
• BARD, A Becton, Dickinson Company
• Biosensors International Group Ltd.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cordis Corporation
• iVascular S.L.U
• Medtronic PLC
• Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.